Cover Image

Commentary: The Clinical Impact of the C0/D Ratio and the CYP3A5 Genotype on Outcome in Tacrolimus Treated Kidney Transplant Recipients

Saved in:

Bibliographic Details
Main Authors:	Gerold Thölking (Author), Stefan Reuter (Author)
Format:	Book
Published:	Frontiers Media S.A., 2021-02-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The Clinical Impact of the C0/D Ratio and the CYP3A5 Genotype on Outcome in Tacrolimus Treated Kidney Transplant Recipients
by: Teun van Gelder, et al.
Published: (2020)

Interaction between tacrolimus and calcium channel blockers based on CYP3A5 genotype in Chinese renal transplant recipients
by: Huiying Zong, et al.
Published: (2024)

Evaluating the Impact of CYP3A5 Genotype on Post-Transplant Healthcare Resource Utilization in Pediatric Renal and Heart Transplant Recipients Receiving Tacrolimus
by: Pasternak AL, et al.
Published: (2021)

CYP3A5 polymorphisms in renal transplant recipients: influence on tacrolimus treatment
by: Chen L, et al.
Published: (2018)

Pharmacokinetics of apixaban and tacrolimus or cyclosporine in kidney and lung transplant recipients
by: Holly Mansell, et al.
Published: (2022)

Pharmacokinetics of tacrolimus according to body composition in recipients of kidney transplants
by: Seung Seok Han, et al.
Published: (2012)

The Effect of Voriconazole on Tacrolimus in Kidney Transplantation Recipients: A Real-World Study
by: Yi-Chang Zhao, et al.
Published: (2022)

Genetic Polymorphisms Affecting Tacrolimus Metabolism and the Relationship to Post-Transplant Outcomes in Kidney Transplant Recipients
by: Cheng F, et al.
Published: (2021)

Limited sampling strategies for estimation of tacrolimus exposure in kidney transplant recipients receiving extended‐release tacrolimus preparation
by: Toqa El‐Nahhas, et al.
Published: (2022)

Investigation of clinical interaction between omeprazole and tacrolimus in CYP3A5 non-expressors, renal transplant recipients
by: Paraskevi F Katsakiori, et al.
Published: (2010)

A randomized crossover study comparing different tacrolimus formulations to reduce intrapatient variability in tacrolimus exposure in kidney transplant recipients
by: Kim L. W. Bunthof, et al.
Published: (2022)

Autophagy in kidney transplants of sirolimus treated recipients
by: Sagar Bhayana, et al.
Published: (2017)

Meltdose Tacrolimus Population Pharmacokinetics and Limited Sampling Strategy Evaluation in Elderly Kidney Transplant Recipients
by: Jasper Kamp, et al.
Published: (2023)

Evaluation of limited-sampling strategies to calculate AUC(0-24) and the role of CYP3A5 in Chilean pediatric kidney recipients using extended-release tacrolimus
by: Carla Galvez, et al.
Published: (2023)

iPTH is not a significant factor influencing the tacrolimus C/D ratio
by: Florian Westphal, et al.
Published: (2022)

Effect of the Interrelation between CYP3A5 Genotype, Concentration/Dose Ratio and Intrapatient Variability of Tacrolimus on Kidney Graft Function: Monte Carlo Simulation Approach
by: Nikola Stefanović, et al.
Published: (2021)

Tacrolimus Updated Guidelines through popPK Modeling: How to Benefit More from CYP3A Pre-emptive Genotyping Prior to Kidney Transplantation
by: Jean-Baptiste Woillard, et al.
Published: (2017)

Effect of cyclosporin and tacrolimus on kidney function in liver recipients
by: Elena D. Kosmacheva, et al.
Published: (2018)

Drug-drug interaction between tacrolimus and caspofungin in Chinese kidney transplant patients with different genotypes
by: Yundi Zhang, et al.
Published: (2024)

Comparison of the long-term efficacy and safety of generic Tacrobell with original tacrolimus (Prograf) in kidney transplant recipients
by: Son SY, et al.
Published: (2017)

CYP3A5 Genotype-Dependent Drug-Drug Interaction Between Tacrolimus and Nifedipine in Chinese Renal Transplant Patients
by: Yilei Yang, et al.
Published: (2021)

Predicting model‐informed precision dosing: A test‐case in tacrolimus dose adaptation for kidney transplant recipients
by: Ruben Faelens, et al.
Published: (2022)

Influence of ensitrelvir or nirmatrelvir/ritonavir on tacrolimus clearance in kidney transplant recipients: a single-center case series
by: Hanako Naganawa, et al.
Published: (2024)

Treatment of acute tacrolimus toxicity with phenytoin after Paxlovid (nirmatrelvir/ritonavir) administration in a kidney transplant recipient
by: Eun-Jeong Kwon, et al.
Published: (2022)

Influence of Genetic Polymorphisms in CYP3A5, CYP3A4, and MDR1 on Tacrolimus Metabolism after kidney transplantation
by: Mirgul Bayanova, et al.
Published: (2024)

CYP3A5 Gene-Guided Tacrolimus Treatment of Living-Donor Egyptian Kidney Transplanted Patients
by: Effrosyni Mendrinou, et al.
Published: (2020)

Tacrolimus pharmacokinetics are influenced by CYP3A5, age, and concomitant fluconazole in pediatric kidney transplant patients
by: Alaa Alghamdi, et al.
Published: (2023)

Association of the PPP3CA c.249G>A variant with clinical outcomes of tacrolimus-based therapy in kidney transplant recipients
by: Salgado PC, et al.
Published: (2017)

Wuzhi Capsule Dosage Affects Tacrolimus Elimination in Adult Kidney Transplant Recipients, as Determined by a Population Pharmacokinetics Analysis
by: Chen L, et al.
Published: (2021)

Age associations with tacrolimus and mycophenolic acid pharmacokinetics in stable Black and White kidney transplant recipients: Implications for health inequities
by: Kathleen M. Tornatore, et al.
Published: (2023)

CYP3A5 genotype-based model to predict tacrolimus dosage in the early postoperative period after living donor liver transplantation
by: Ji E, et al.
Published: (2018)

Statin therapy for preventing cardiovascular diseases in patients treated with tacrolimus after kidney transplantation
by: Han N, et al.
Published: (2017)

Relationship between CYP3A5 Polymorphism and Tacrolimus Blood Concentration Changes in Allogeneic Hematopoietic Stem Cell Transplant Recipients during Continuous Infusion
by: Naoki Yoshikawa, et al.
Published: (2021)

Role of Tacrolimus C/D Ratio in the First Year After Pediatric Liver Transplantation
by: Benas Prusinskas, et al.
Published: (2021)

Pharmacogenetics Based Dose Prediction Model for Initial Tacrolimus Dosing in Renal Transplant Recipients
by: Lekshmy Srinivas, et al.
Published: (2021)

Tacrolimus Pharmacokinetic and Pharmacogenomic Differences between Adults and Pediatric Solid Organ Transplant Recipients
by: Amy Lu, et al.
Published: (2010)

Effects of <i>CYP3A5</i> Genotype on Tacrolimus Pharmacokinetics and Graft-versus-Host Disease Incidence in Allogeneic Hematopoietic Stem Cell Transplantation
by: Daniel N. Marco, et al.
Published: (2024)

Cutaneous protothecosis in kidney transplant recipient,
by: Valeria Romero Godofredo, et al.
Published: (2020)

Hypertension in the Pediatric Kidney Transplant Recipient
by: Asha Moudgil, et al.
Published: (2017)

Immunologic monitoring in kidney transplant recipients
by: Natavudh Townamchai, et al.
Published: (2013)